Cytotoxic CD8<sup>+</sup> T Cells Are Involved in the Thrombo-Inflammatory Response during First-Diagnosed Atrial Fibrillation
Background: Atrial myopathy and atrial fibrillation (AF) accompany thrombo-inflammation. This facilitates disease progression and promotes major adverse cardiovascular events (MACEs). Thrombin receptor (protease-activated receptor 1, PAR1) signalling is central in mediating thrombo-inflammation. We...
Main Authors: | Julian Friebel, Marco Witkowski, Max Wegner, Leon Blöbaum, Stella Lammel, Philipp-Alexander Schencke, Kai Jakobs, Marianna Puccini, Daniela Reißner, Daniel Steffens, Verena Moos, Heinz-Peter Schutheiss, Ulf Landmesser, Ursula Rauch |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-12-01
|
Series: | Cells |
Subjects: | |
Online Access: | https://www.mdpi.com/2073-4409/12/1/141 |
Similar Items
-
Characterization of Biomarkers of Thrombo-Inflammation in Patients with First-Diagnosed Atrial Fibrillation
by: Julian Friebel, et al.
Published: (2024-04-01) -
Pleiotropic Effects of the Protease-Activated Receptor 1 (PAR1) Inhibitor, Vorapaxar, on Atherosclerosis and Vascular Inflammation
by: Julian Friebel, et al.
Published: (2021-12-01) -
Intestinal Barrier Dysfunction and Microbial Translocation in Patients with First-Diagnosed Atrial Fibrillation
by: Leon Blöbaum, et al.
Published: (2023-01-01) -
Thromboembolic and hemorrhagic risk stratification in patients with atrial fibrillation. Part I: the thromboembolic risk
by: Maurizio Giuseppe Abrignani, et al.
Published: (2015-11-01) -
Platelet in thrombo-inflammation: Unraveling new therapeutic targets
by: Swati Sharma, et al.
Published: (2022-11-01)